Zurcher Kantonalbank (Zurich Cantonalbank) Neurocrine Biosciences Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$33.8 Billion
Q1 2025

A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 114,765 shares of NBIX stock, worth $14.3 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

114,765

Previous 61,260 87.34%

Holding current value

$14.3 Million

Previous $8.36 Million 51.81%

% of portfolio

0.04%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$107.22 - $153.29 $5.74 Million - $8.2 Million	53,505 Added 87.34%	114,765 $12.7 Million
Q4 2024 Feb 07, 2025	BUY	$111.62 - $139.44 $40,183 - $50,198	360 Added 0.59%	61,260 $8.36 Million
Q3 2024 Nov 07, 2024	SELL	$114.58 - $153.15 $3.34 Million - $4.46 Million	-29,118 Reduced 32.35%	60,900 $7.01 Million
Q2 2024 Jul 29, 2024	BUY	$130.86 - $143.19 $3.43 Million - $3.75 Million	26,195 Added 41.04%	90,018 $12.4 Million
Q1 2024 Apr 25, 2024	BUY	$130.4 - $143.74 $2.46 Million - $2.71 Million	18,884 Added 42.02%	63,823 $8.8 Million
Q4 2023 Jan 30, 2024	BUY	$106.07 - $132.76 $2.68 Million - $3.35 Million	25,245 Added 128.19%	44,939 $5.92 Million
Q3 2023 Oct 25, 2023	SELL	$94.02 - $117.1 $37,608 - $46,840	-400 Reduced 1.99%	19,694 $2.22 Million
Q2 2023 Aug 07, 2023	BUY	$89.53 - $104.87 $447 - $524	5 Added 0.02%	20,094 $1.89 Million
Q1 2023 May 08, 2023	BUY	$94.11 - $123.02 $15,810 - $20,667	168 Added 0.84%	20,089 $2.03 Million
Q4 2022 Feb 01, 2023	SELL	$106.72 - $127.06 $83,775 - $99,742	-785 Reduced 3.79%	19,921 $2.38 Million
Q3 2022 Nov 09, 2022	BUY	$92.03 - $107.81 $79,974 - $93,686	869 Added 4.38%	20,706 $2.2 Million
Q2 2022 Aug 09, 2022	BUY	$75.79 - $100.07 $132,784 - $175,322	1,752 Added 9.69%	19,837 $1.93 Million
Q1 2022 Apr 21, 2022	SELL	$72.45 - $94.81 $6,592 - $8,627	-91 Reduced 0.5%	18,085 $1.7 Million
Q4 2021 Feb 01, 2022	SELL	$79.65 - $106.22 $155,875 - $207,872	-1,957 Reduced 9.72%	18,176 $1.55 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $7,152 - $8,219	-83 Reduced 0.41%	20,133 $1.93 Million
Q2 2021 Jul 30, 2021	BUY	$89.43 - $102.27 $16,097 - $18,408	180 Added 0.9%	20,216 $1.97 Million
Q1 2021 May 03, 2021	BUY	$87.57 - $119.4 $442,841 - $603,805	5,057 Added 33.76%	20,036 $1.95 Million
Q4 2020 Jan 28, 2021	SELL	$86.91 - $108.33 $1.06 Million - $1.33 Million	-12,240 Reduced 44.97%	14,979 $1.44 Million
Q3 2020 Nov 06, 2020	BUY	$96.16 - $135.15 $481,953 - $677,371	5,012 Added 22.57%	27,219 $2.62 Million
Q2 2020 Jul 28, 2020	BUY	$85.09 - $130.36 $275,521 - $422,105	3,238 Added 17.07%	22,207 $2.71 Million
Q1 2020 May 06, 2020	BUY	$75.11 - $113.76 $80,593 - $122,064	1,073 Added 6.0%	18,969 $1.64 Million
Q4 2019 Jan 21, 2020	BUY	$86.8 - $118.57 $1.05 Million - $1.44 Million	12,153 Added 211.61%	17,896 $1.92 Million
Q3 2019 Oct 18, 2019	BUY	$83.82 - $101.5 $41,658 - $50,445	497 Added 9.47%	5,743 $518,000
Q1 2019 Apr 29, 2019	SELL	$69.31 - $91.53 $60,299 - $79,631	-870 Reduced 14.22%	5,246 $462,000
Q4 2018 Jan 25, 2019	BUY	$68.32 - $124.36 $30,607 - $55,713	448 Added 7.9%	6,116 $437,000
Q3 2018 Nov 09, 2018	BUY	$98.88 - $125.85 $15,721 - $20,010	159 Added 2.89%	5,668 $697,000
Q2 2018 Aug 06, 2018	BUY	$75.3 - $105.99 $26,505 - $37,308	352 Added 6.83%	5,509 $541,000
Q1 2018 May 03, 2018	SELL	$75.88 - $92.43 $56,682 - $69,045	-747 Reduced 12.65%	5,157 $428,000
Q4 2017 Jan 31, 2018	BUY	$58.53 - $77.59 $70,236 - $93,108	1,200 Added 25.51%	5,904 $458,000
Q3 2017 Nov 08, 2017	BUY	$47.97 - $61.28 $225,650 - $288,261	4,704	4,704 $288,000

Others Institutions Holding NBIX

# of Institutions

650

Shares Held

97.2M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.9B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account

Zurcher Kantonalbank (Zurich Cantonalbank) Neurocrine Biosciences Inc Transaction History